| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income (loss) | 5,661 | 14,570 | 7,074 | 11,832 |
| Depreciation | 4,856 | 4,930 | 5,023 | 10,018 |
| Amortization of identifiable intangibles | 440 | 439 | 440 | 879 |
| Goodwill impairment | NaN | 0 | NaN | NaN |
| Reduction of right-of-use leased assets | 543 | 531 | 520 | 1,064 |
| Deferred income taxes | 429 | 3,351 | 1,664 | 1,209 |
| Accrued pension and post-retirement benefits | 39 | 27 | 27 | 107 |
| Opeb termination gain | NaN | 6,265 | NaN | NaN |
| Gain on investment in kalo | NaN | 0 | 0 | 0 |
| Production equipment asset impairment | NaN | 843 | NaN | NaN |
| Pension settlement loss and (gain) on other post-retirement benefits termination | NaN | 0 | NaN | NaN |
| Gain on the sale of assets | NaN | 0 | 5 | 1,492 |
| Stock-based compensation expense | 454 | 49 | 840 | 919 |
| Impairment of richmond, virginia technical center assets | NaN | 0 | NaN | NaN |
| Gain on the sale of divested business | 565 | 0 | 0 | 9,657 |
| Accounts and other receivables | 11,888 | -6,121 | 9,097 | 14,016 |
| Inventories | 19,105 | 2,948 | -4,648 | 15,263 |
| Income taxes recoverable/payable | -436 | -200 | -238 | 349 |
| Prepaid expenses and other | -6,739 | 3,841 | 2,988 | -8,897 |
| Accounts payable and accrued expenses | 13,956 | -839 | 12,071 | 2,336 |
| Lease liability | 640 | 622 | 560 | 1,240 |
| Pension and postretirement benefit plan contributions | 26 | 127 | 139 | 291 |
| Other, net | 624 | -710 | 364 | 2,195 |
| Net cash provided by (used in) operating activities | 1,953 | 15,709 | 20,120 | -2,852 |
| Proceeds from the sale of assets | NaN | 0 | 0 | 1,904 |
| Capital expenditures | 5,141 | 7,995 | 3,608 | 5,638 |
| Proceeds from the sale of kalo | NaN | 0 | 0 | 0 |
| Proceeds from the sale of terphane | 565 | 0 | 0 | 9,835 |
| Net cash (used in) provided by investing activities | -4,576 | -7,995 | -3,608 | 6,101 |
| Borrowings | 49,950 | 19,643 | 15,550 | 88,197 |
| Debt principal payments | 38,700 | 34,100 | 28,679 | 87,494 |
| Dividends paid | NaN | 0 | NaN | NaN |
| Debt financing costs | NaN | 0 | 0 | 1,272 |
| Net cash provided by (used in) financing activities | 11,250 | -14,457 | -13,129 | -569 |
| Effect of exchange rate changes on cash | 255 | 181 | 113 | 53 |
| Increase (decrease) in cash and cash equivalents | 8,882 | -6,562 | 3,496 | 2,733 |
| Cash and cash equivalents at beginning of period | 6,729 | 13,291 | 7,062 | NaN |
| Cash and cash equivalents at end of period | 15,611 | 6,729 | 13,291 | NaN |
TREDEGAR CORP (TG)
TREDEGAR CORP (TG)